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It was shown in previous work that the interaction of growth factors (GFs) with adenosine
triphosphate (ATP) is essential for their neuroprotective effect. Here we investigated the
nature of the association of human basic fibroblast growth factor (bFGF), nerve growth factor
(NGF), and brain-derived neurotrophic factor (BDNF) with ATP. It was demonstrated that this
interaction involves the formation of non-covalent ATP-GF complexes that are labile at low pH
and that could be selectively purified and subjected to electrospray and MALDI-TOF mass
spectrometry. The results obtained with these techniques indicated that the stability of the
complexes is high. Main features of the procedure used here are: (1) reversed-phase
purification of nucleotide–protein non-covalent complexes, (2) their detection with MALDI-
TOF-MS using acid-free matrix, and/or (3) their measurement with ESI-MS using soft
desolvation conditions. The methodology was successful in providing proof for the presence
of various nucleotide-GF complexes. It was extended to other nucleotide-binding proteins
(ribonuclease A) as well as proteins that do not exhibit nucleotide binding (lysozyme) as
positive and negative control, respectively. Thus, the method demonstrated its general use for
the investigation of a wide range of proteins interacting with nucleotides as long as their
complexes are sufficiently stable to accommodate the experimental conditions. (J Am Soc
Mass Spectrom 2008, 19, 91–95) © 2008 American Society for Mass SpectrometryThe interaction of growth factors (GFs) such ashuman basic fibroblast growth factor (bFGF,17,052 Da), nerve growth factor (NGF, 13,261 Da),
and brain-derived neurotrophic factor (BDNF, 13,506
Da) with adenosine triphosphate (ATP) has only re-
cently been discovered and it has been shown to be
essential for their neuroprotective effect [1]. Radioactive
labeling of the GFs with [-32P]ATP was destroyed at
low pH, but was stable in basic buffers. The association
of ATP with bFGF was still detectable after denaturing
gel electrophoresis. Because no autokinase activity of
the GFs was known, covalent phosphorylation did not
seem likely. Nevertheless, both covalent and non-cova-
lent interactions were investigated by using electro-
spray ionization (ESI) and matrix-assisted laser/de-
sorption ionization time-of-flight mass spectrometry
(MALDI-TOF-MS).
MS-detection of N- or acylphosphates is not far
advanced due to the difficulties associated with the acid
lability of the modification [2–6]. The investigation of
non-covalent binding in the gas phase is also not trivial
because complexes that are stable in liquid medium
may not be observed easily in the gas phase [7]. Even
when signals are detected the question remains to what
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the case of nucleotide binding to proteins it needs to be
considered that nucleotides themselves are acid-labile
and thus demand moderate assay conditions. Only few
studies have documented the use of MS for the analysis
of protein–nucleotide complexes [8–11]. The authors of
these studies all electrospray the complexes from a
solution containing the necessary components (cations,
nucleotide, protein) and a volatile buffer imitating
physiological conditions. However, both in MALDI and
ESI unspecific gas-phase adduct formation needs to be
considered to different degrees. Attempts to avoid
adducts involve harsher desolvation conditions (i.e.,
high temperature) and they put strain on non-covalent
complexes as well. Therefore, the measurement of pro-
tein complexes with MS requires a sufficiently stable
bond as well as a delicate balance of the experimental
parameters. Here, we present a method that allows the
preservation of nucleotide–protein complexes and their
detection with soft ionization MS [12].
Experimental
Chemicals were purchased from Sigma–Aldrich
(Seelze, Germany) unless otherwise noted. Commercial
NGF and BDNF for comparative experiments were
obtained from Acris (Hiddenhausen, Germany). The
plasmids pET11a-proNGF or pET11a-proBDNF were a
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many) and P. Madsen (University of Aarhus, Den-
mark), respectively.
Recombinant human GFs were expressed in Esche-
richia coli. bFGF was expressed and purified as previ-
ously described after deletion of the codon for the
second amino acid (alanine) in the sequence of the bFGF
gene [1]. Expression of NGF and BDNF in the presence
of their covalently attached pro-domain in E. coli
Rosetta(DE3)pLysS carrying the plasmids pET11a-
proNGF or pET11a-proBDNF, respectively, led to the
formation of inclusion bodies. After their solubilization,
proNGF and proBDNF were refolded and purified as
described by Rattenholl and colleagues [13] (except that
for BDNF no hydrophobic interaction chromatography
was performed) with subsequent cleavage of the pro-
peptides by trypsin. Labeling of GF proteins (5 g bFGF
or 3.5 g NGF or BDNF) was carried out at 37 °C for 15
and 30 min, respectively, in a volume of 15 L contain-
ing 25 mM Tris/HCl (pH 7.5) and 0.1 mM ATP. For
labeling of bFGF 0.1 mM MgCl2 and 1 mM DTT were
added, whereas NGF and BDNF were incubated with
0.1 mM MnCl2. Ribonuclease A from bovine pancreas
(7.5 g) and lysozyme from chicken egg white (3.5 g)
were treated with ATP in the same way as described for
GFs, except that no cations were added for labeling of
ribonuclease A.
For purification of the protein and its complex,
ZipTips C4 (Millipore, Bedford, MA, USA) were
washed with elution buffer (80% methanol, 0.1% acetic
acid) and equilibrated using aqueous solvent (5% meth-
anol, 0.1% acetic acid). For sample binding, 10 L of
solutions of GFs (3 mg/mL) or control proteins (3
mg/mL) were applied and rinsed with equilibration
solution. The purified complexes of NGF and BDNF
with ATP were eluted in 5 L and bFGF-ATP in 10 L
elution solvent.
For MALDI-MS MALDImicroMX (Waters Corp.,
Milford, MA, USA) was used in positive linear mode.
After preparation of the target with 0.5 L of 10 mg/mL
sinapinic acid in acetone, 0.5 L of each sample, and 10
mg/mL sinapinic acid in 40% acetonitrile were added.
For partial proteolysis of NGF trypsin was used in a
ratio of 1:40. Samples were analyzed by MS after 0, 1, 2,
5, 7, 10, and 30 min of incubation at 37 °C. ESI-MS was
performed with Esquire3000 (Bruker Daltonics, Bremen,
Germany) using a modified manual liquid-junction
nanospray source with self-pulled capillaries [14]. Dry-
ing gas was maintained at 100 °C. As mentioned in the
text either normal or extended mass range was used
applying a trap target mass as given later in Figure 3.
Results and Discussion
We adjusted all protocols to accommodate the acid-
labile character of the protein modification. So far, there
was no mass spectrometric evidence for the covalent
attachment of phosphate groups to GFs. However, our
results indicated the formation of ATP-GF non-covalentcomplexes. Methods for the investigation of non-cova-
lent binding of proteins using MS require optimization
concerning buffers and experimental parameters. Phys-
iological buffers that are needed to preserve the com-
plex tend to suppress the analyte signal. Usually, vola-
tile buffers such as ammonium bicarbonate or acetate
are used as a compromise. This approach was not
successful here. However, derived from the efforts of
providing high-pH conditions parameters were found
that allowed the detection of ATP-GF complexes. For
the removal of residual contaminants in GF samples
dialysis and solid-phase extraction worked best. In fact,
desalting using C4 material allowed us to purify the
ATP-GF complexes when harsh solvents were avoided.
Methanol was used instead of acetonitrile and a weak
acid (formic or acetic) was added. The latter turned out
to be crucial; otherwise, MS signals were noisy and
unresolved. Labeling of GFs with ATP was resistant to
low-pH treatment during this procedure as could be
demonstrated using autoradiography. The flowchart of
the desalting procedure is depicted in Figure 1.
Although well-resolved spectra of intact NGF (see
Figure 3a), bFGF and BDNF could be generated with an
ion trap, only MALDI-TOF-MS allowed detection of the
purified ATP complexes at first. As shown in Figure 2
the attachment of one and two nucleotide molecules
and a divalent cation to NGF and bFGF was observed.
Unspecific adduct formation could be excluded because
excess unbound ATP and cations were removed by the
purification step. Protein-free control experiments re-
vealed that only 1% of unbound [-32P]ATP was trans-
Figure 1. Scheme of the workflow for the detection of non-
covalent complexes of GF proteins with nucleotides. The protein
image of NGF was modeled using PDB entry 1BET. Triangles
symbolize ATP, circles the divalent cation, and squares buffer
ions. (a) GF was incubated with ATP and Mg2 or Mn2. (b) Salts
and unbound material were removed using reversed-phase mate-
rial. (c) The purified complex was measured in MALDI-TOF and
ESI-MS. (d) The procedures were applied to structural investiga-
tions such as time-dependent proteolysis. The structure was
visualized using PDB entry 1BET and CS Chem3D Pro 3.5.1. Two
molecules of ATP were added for size comparison.ferred to the eluate. However, breakdown of complex
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have been partially responsible for the GF ions contain-
ing one or no ATP molecule. Complexation of two
molecules of ATP assisted by the binding of one cation
appeared to be the natural process that confirmed
previously published data showing the labeling of
bFGF, NGF, and BDNF with [-32P]ATP and the inter-
action of bFGF with [-32P]ATP [1]. The stability of the
complexes appeared to be high because they survived
the purification procedure.
The MALDI matrix had to be acid free, however.
Although the addition of TFA to the MALDI matrix
proved to be important for preventing solvent adducts
to the protein peaks, it also eliminated any signal from
the non-covalent complex. Therefore, the observed ad-
ducts of 98 Da (Figure 2) could not be easily avoided.
These satellite peaks were present in all GF samples
tested, including commercial products independent of
treatment with ATP. Labeling of GFs with radioactive
ortho-phosphate was not detectable. Although the pres-
ence of phosphoric acid or sulfate is suggested by the
mass difference, so far the nature of these adducts
remains ambiguous to us and to other authors [8, 15,
16].
Different MS techniques can often provide comple-
mentary information and, in this case, the resolution of
protein charge states was expected using ESI-MS. The
Esquire3000 ion trap was available for that purpose.
Although this analyzer type is not commonly used for
the measurement of natural complexes, it has been
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Figure 2. MALDI-TOF spectrum of purified N
ions and low abundant cleavage products at12
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molecules of ATP (507.2 g/mol) and one corre
g/mol) were complexed and appear as addition
further annotations see Figure 1.shown that it is possible to detect multimers of bovineserum albumin and alcohol dehydrogenase with the
commercial instrument [17]. More specific experiments
such as the collision-induced dissociation measure-
ments of trypsin/trypsin inhibitor complexes were per-
formed on modified instrumental configurations [15].
Soft desolvation conditions were applied to preserve
the complex of ATP with GFs. As depicted in Figure 3a
for NGF, the use of the trap’s different measurement
ranges allowed us to observe several ion populations.
Signals could be detected for unfolded and partially
folded NGF monomers as well as dimers, the naturally
occurring state of NGF [18]. For bFGF and BDNF no
multimers were detected. However, the addition of
ATP caused the peaks of the higher mass/lower charge
ions to broaden with very little resolution of the indi-
vidual molecular species in the case of bFGF and NGF
(data not shown). Nevertheless, the BDNF–ATP com-
plex could be observed with resolved charge-state en-
velopes of all complex ion species (Figure 3b).
Although the protocol was applied to bFGF, NGF,
and BDNF in the same way, the proteins differed in
their behavior and that was likely associated with
structural properties. Purification of bFGF seemed to be
less successful than that of NGF and BDNF, possibly
due to its spherical structure [19] (Protein Databank
PDB entry 1BAS) hindering salt diffusion. In contrast,
NGF (1BET) and BDNF (1BND) folding is determined
by three disulfide bridges and an elongated -sheet
structure [20]. The stability of the various complexes
had to be tested individually because some survive
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investigations with regard to complex formation in
different systems changing the cation or the structure of
the nucleotide and it has proven to be reliable. Its
specificity was verified using ribonuclease A and ly-
sozyme for controls. Ribonuclease A is known to bind
ATP [8, 21]. By applying our method we could demon-
strate an ATP–ribonuclease A-complex. Lysozyme was
used as a negative control. It has a pI in the basic range
similar to that of GFs and there is no evidence for
binding of ATP [22]. Accordingly, no complex forma-
tion between lysozyme and ATP could be observed
using this methodology. Therefore, we can exclude that
solely an ionic effect contributes to the interactions
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Figure 3. (a) Ion trap data of purified native NGF. Charge state
envelopes were observed for the monomer at trap target mass
2000 accompanied by residual 98 Da satellite peaks (see text).
Changing analyzer parameters brings up ions for the NGF dimer
(center spectrum), which can be further enhanced monitoring the
ion population in the high mass range (top right). (b) Ion trap
spectrum of purified BDNF-ATP complex at trap target mass 900.
The spectrum is complex due to the presence of a second smaller
protein, which supposedly is a cleavage product of BDNF derived
from the tryptic removal of the pro-peptide during the production
process of the GF. So far, it could not be removed without loss of
activity of BDNF. The smaller protein also binds ATP and the
corresponding charge state envelopes partially overlap those for
BDNF. For annotations see Figure 1.between the GFs and ATP.The technique also allowed the time-dependent pro-
teolytic digestion for further structure elucidation with
the goal of localizing regions of the protein that are
important for ATP binding. Complex decomposition
turned out to be a fast reaction observable within only
a few minutes. In the case of the globular structure of
bFGF the results were of limited value; however, for
NGF the loss of the N-terminal peptide SSSHPIFHR
(amino acids 1–9) and the peptide EVMVLG EVN-
INNSVFK (amino acids 35–50; located at the top edge of
the structure shown in Figure 1) did not seem to affect
complex stability. The latter peptide is located the
farthest away from the three disulfide bonds that de-
termine the NGF structure and possibly also provide a
stable groove for ATP binding. Currently, investiga-
tions are under way to elucidate the crystal structure of
GF–ATP complexes.
Conclusions
The nature of the interaction of GF proteins and nucle-
otides was investigated. The formation of non-covalent
ATP-GF complexes could be shown by the methodol-
ogy introduced here that allows their selective purifica-
tion and detection with MS. Main features of the
procedure are: (1) reversed-phase purification of nucle-
otide–protein non-covalent complexes, (2) their detec-
tion with MALDI-TOF-MS using acid-free matrix,
and/or (3) their measurement with ESI-MS. The
method is not limited to the analysis of GFs, but might
be expanded for the investigation of a wide range of
proteins interacting with nucleotides as long as the
complexes are sufficiently stable. The further character-
ization of their binding parameters is a prime task.
Preliminary experiments suggest that one of the two
presumed ATP-binding sites is located close to the three
disulfide bridges in NGF.
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